CD8A and lung cancer: To conduct feasible applications of liposomes in tumor immunotherapy, cationic liposomes containing synthetic tumor long peptides have been designed and prepared, and such nanoparticle vaccines have been demonstrated to stimulate both CD4+ and CD8+ T cells and enhance the efficacy of a checkpoint inhibitor for lung cancer [52].